Compass Therapeutics Inc (CMPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1993 | 06-1992 | 06-1991 | 06-1990 | 06-1989 | |
| Assets | |||||
| Current Assets | |||||
| Inventories | N/A | 1,437 | 1,726 | 1,778 | 955 |
| Other current assets | 460 | 688 | 161 | 151 | 117 |
| TOTAL | $460 | $2,125 | $1,887 | $1,928 | $1,072 |
| Non-Current Assets | |||||
| PPE Net | 1,235 | 778 | 419 | 277 | 334 |
| Other Non-Current Assets | 0 | 252 | 210 | 398 | 585 |
| TOTAL | $1,235 | $1,030 | $629 | $674 | $920 |
| Total Assets | $1,695 | $3,155 | $2,516 | $2,603 | $1,992 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 50 | 37 | 0 | 0 |
| Accounts payable and accrued liabilities | 712 | 433 | 532 | 495 | 170 |
| Accrued Expenses | 635 | 291 | 243 | 193 | 215 |
| Other current liabilities | 0 | 0 | 0 | 0 | 6 |
| TOTAL | $2,152 | $1,304 | $1,122 | $687 | $601 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $17 | $8 | $20 |
| Total Liabilities | $2,152 | $1,304 | $1,139 | $695 | $621 |
| Shareholders' Equity | |||||
| Common Shares | 336 | 209 | 205 | 203 | 202 |
| TOTAL | $3,590 | $2,652 | $2,640 | $2,602 | $2,588 |
| Total Liabilities And Equity | $5,742 | $3,956 | $3,779 | $3,298 | $3,209 |